Khiron Life Sciences Corp

Company Profile

Khiron Life Sciences Corp had its IPO on under the ticker symbol KHRNF.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Khiron Life Sciences Corp has a staff strength of 0 employees.

Stock update

Shares of Khiron Life Sciences Corp opened at $0.01 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.01 - $0.01, and closed at $0.01.

This is a +6% increase from the previous day's closing price.

A total volume of 173,176 shares were traded at the close of the day’s session.

In the last one week, shares of Khiron Life Sciences Corp have slipped by -24.29%.

Khiron Life Sciences Corp's Key Ratios

Khiron Life Sciences Corp has a market cap of $6.97 million, indicating a price to book ratio of 0.4495 and a price to sales ratio of 0.5404.

In the last 12-months Khiron Life Sciences Corp’s revenue was $16.14 million with a gross profit of $6.37 million and an EBITDA of $-16406023. The EBITDA ratio measures Khiron Life Sciences Corp's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Khiron Life Sciences Corp’s operating margin was -108.07% while its return on assets stood at -20.79% with a return of equity of -74.68%.

In Q3, Khiron Life Sciences Corp’s quarterly earnings growth was a positive 0% while revenue growth was a negative 3.8%.

Khiron Life Sciences Corp’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-0.11 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Khiron Life Sciences Corp’s profitability.

Khiron Life Sciences Corp stock is trading at a EV to sales ratio of 0.5695 and a EV to EBITDA ratio of -0.3215. Its price to sales ratio in the trailing 12-months stood at 0.5404.

Khiron Life Sciences Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$38.45 million

Total Liabilities

$9.06 million

Operating Cash Flow

$-872000.00

Capital Expenditure

$749000

Dividend Payout Ratio

0%

Khiron Life Sciences Corp ended 2024 with $38.45 million in total assets and $0 in total liabilities. Its intangible assets were valued at $38.45 million while shareholder equity stood at $27.10 million.

Khiron Life Sciences Corp ended 2024 with $0 in deferred long-term liabilities, $9.06 million in other current liabilities, 151868000.00 in common stock, $-127971000.00 in retained earnings and $6.11 million in goodwill. Its cash balance stood at $1.94 million and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $1.34 million.

Khiron Life Sciences Corp’s total current assets stands at $18.33 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $4.54 million compared to accounts payable of $6.76 million and inventory worth $9.81 million.

In 2024, Khiron Life Sciences Corp's operating cash flow was $-872000.00 while its capital expenditure stood at $749000.

Comparatively, Khiron Life Sciences Corp paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0.01

52-Week High

$0.126

52-Week Low

$0.009

Analyst Target Price

$

Khiron Life Sciences Corp stock is currently trading at $0.01 per share. It touched a 52-week high of $0.126 and a 52-week low of $0.126. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.02 and 200-day moving average was $0.04 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 464.2% of the company’s stock are held by insiders while 21.6% are held by institutions.